SYM 0.00% $2.63 symbio holdings limited

Just More Of The Same

  1. 457 Posts.
    lightbulb Created with Sketch. 105
    Revenue Up 28%
    NPAT Up 40%
    EPS Up 33%

    Beat guidance on EBITDA by about 5%.

    More of the same by a high quality company. Many ASX companies should study MNF as a blueprint on how to make considered, smart acquisition (without debt) that actually contribute to the growth of the company from the outset. EPS has increased five-fold in the 3 years, that says it all.

    Few companies with well-regarded managers come out and say that they are "very confident" of strong growth ahead. That's what we have here.
 
watchlist Created with Sketch. Add SYM (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.